Your browser doesn't support javascript.
loading
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
Vasan, Sandhya; Schlesinger, Sarah J; Chen, Zhiwei; Hurley, Arlene; Lombardo, Angela; Than, Soe; Adesanya, Phumla; Bunce, Catherine; Boaz, Mark; Boyle, Rosanne; Sayeed, Eddy; Clark, Lorna; Dugin, Daniel; Boente-Carrera, Mar; Schmidt, Claudia; Fang, Qing; Huang, Yaoxing; Zaharatos, Gerasimos J; Gardiner, David F; Caskey, Marina; Seamons, Laura; Ho, Martin; Dally, Len; Smith, Carol; Cox, Josephine; Gill, Dilbinder; Gilmour, Jill; Keefer, Michael C; Fast, Patricia; Ho, David D.
Affiliation
  • Vasan S; Aaron Diamond AIDS Research Center, New York, New York, United States of America. svasan@adarc.org
PLoS One ; 5(1): e8816, 2010 Jan 25.
Article in En | MEDLINE | ID: mdl-20111599
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia virus / HIV-1 / AIDS Vaccines Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2010 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia virus / HIV-1 / AIDS Vaccines Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2010 Type: Article Affiliation country: United States